Orion Biotechnology

Provider of biologic therapeutics for addressing obesity and metabolic disorders through the development of next-generation GPCRs

placeOttawa, Ontario, Canada calendar_todayFounded 2011 groups21 employees language orionbiotechnology.com

Registered entities

Social engagement

Social engagement: 2K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include Keiretsu Forum.

Investor typeCountShare
Venture capital233%
Accelerator & incubator233%
Other / undisclosed233%
Coming soon